Digital recruitment and enrollment in a remote nationwide trial of screening for undiagnosed atrial fibrillation: Lessons from the randomized, controlled mSToPS trial

Katie Baca-Motes, Alison M Edwards, Jill Waalen, Shawn Edmonds, Rajesh R Mehta, Lauren Ariniello, Gail S Ebner, Dimitri Talantov, John M Fastenau, Chureen T Carter, Troy C Sarich, Elise Felicione, Eric J Topol, Steven R Steinhubl, Katie Baca-Motes, Alison M Edwards, Jill Waalen, Shawn Edmonds, Rajesh R Mehta, Lauren Ariniello, Gail S Ebner, Dimitri Talantov, John M Fastenau, Chureen T Carter, Troy C Sarich, Elise Felicione, Eric J Topol, Steven R Steinhubl

Abstract

Objectives: The advent of large databases, wearable technology, and novel communications methods has the potential to expand the pool of candidate research participants and offer them the flexibility and convenience of participating in remote research. However, reports of their effectiveness are sparse. We assessed the use of various forms of outreach within a nationwide randomized clinical trial being conducted entirely by remote means.

Methods: Candidate participants at possibly higher risk for atrial fibrillation were identified by means of a large insurance claims database and invited to participate in the study by their insurance provider. Enrolled participants were randomly assigned to one of two groups testing a wearable sensor device for detection of the arrhythmia.

Results: Over 10 months, the various outreach methods used resulted in enrollment of 2659 participants meeting eligibility criteria. Starting with a baseline enrollment rate of 0.8% in response to an email invitation, the recruitment campaign was iteratively optimized to ultimately include website changes and the use of a five-step outreach process (three short, personalized emails and two direct mailers) that highlighted the appeal of new technology used in the study, resulting in an enrollment rate of 9.4%. Messaging that highlighted access to new technology outperformed both appeals to altruism and appeals that highlighted accessing personal health information.

Conclusions: Targeted outreach, enrollment, and management of large remote clinical trials is feasible and can be improved with an iterative approach, although more work is needed to learn how to best recruit and retain potential research participants.

Trial registration: Clinicaltrials.govNCT02506244. Registered 23 July 2015.

Keywords: AF, atrial fibrillation; Clinical research; Clinical trials; Digital technology; ECG, electrocardiographic; ICF, informed consent form; Outreach; Remote enrollment; Remote monitoring; mSToPS, mHealth Screening to Prevent Strokes.

Figures

Fig. 1
Fig. 1
Timeline for email and direct-mail campaigns.
Fig. 2
Fig. 2
Enrollment rates by campaign type. The denominator for each group is the number of candidate participants who received each type of communication. PHI - personal health information. *p < 0.01 versus each of the other subject lines. †p < 0.01 versus Control and New Technology. ‡p < 0.01 versus Control.

References

    1. Tice D.G., Carroll K.A., Bhatt K.H., Belknap S.M., Mai D., Gipson H.J., West D.P. Characteristics and causes for non-accrued clinical research (NACR) at an academic medical institution. J. Clin. Med. Res. 2013;5:185–193. doi: 10.4021/jocmr1320w.
    1. Steinhubl S.R., McGovern P., Dylan J., Topol E.J. The digitised clinical trial. Lancet. 2017;390:21–35. doi: 10.1016/S0140-6736(17)32741-1.
    1. VanEpps E.M., Volpp K.G., Halpern S.D. A nudge toward participation: improving clinical trial enrollment with behavioral economics. Sci. Transl. Med. 2016;8:348fs13. doi: 10.1126/scitranslmed.aaf0946.
    1. Steinhubl S.R., Mehta R.R., Ebner G.S., Ballesteros M.M., Waalen J., Steinberg G., Van Crocker P., Jr., Felicione E., Carter C.T., Edmonds S., Honcz J.P., Miralles G.D., Talantov D., Sarich T.C., Topol E.J. Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: the mHealth Screening To Prevent Strokes (mSToPS) trial. Am. Heart J. 2016;175:77–85. doi: 10.1016/j.ahj.2016.02.011.
    1. Steinhubl S.R., Waalen J., Edwards A.M., Ariniello L.M., Mehta R.R., Ebner G.S., Carter C., Baca-Motes K., Felicione E., Sarich T., Topol E.J. Effect of a home-based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation: the mSToPS randomized clinical trial. JAMA. 2018;320:146–155. doi: 10.1001/jama.2018.8102.
    1. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham Study. Arch. Intern. Med. 1987;147:1561–1564.
    1. Caldwell J.C., Contractor H., Petkar S., Ali R., Clarke B., Garratt C.J., Neyses L., Mamas M.A. Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy. Europace. 2009;11:1295–1300. doi: 10.1093/europace/eup201.
    1. American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations) J. Am. Coll. Cardiol. 2013;1:1935–1944. doi: 10.1016/j.jacc.2013.02.001.
    1. Sugarman J., Kass N.E., Goodman S.N., Perentesis P., Fernandes P., Faden RR R.R. What patients say about medical research. IRB. 1998;20:1–7.
    1. Bobb M.R., Van Heukelom P.G., Faine B.A., Ahmed A., Messerly J.T., Bell G., Harland K.K., Simon C., Mohr N.M. Telemedicine provides noninferior research informed consent for remote study enrollment: a randomized controlled trial. Acad. Emerg. Med. 2016;7:759–765. doi: 10.1111/acem.12966.
    1. Center for Information and Study on Clinical Research Participation (CISCRP) 2017. 2017 Perceptions & insights study: report on the participation experience.

Source: PubMed

3
Abonnere